Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Real-world analyses suggest link to reduced steroid use, fewer hospital stays, lower morta ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...

Early studies suggest GLP-1 drugs like Ozempic may reduce cravings for alcohol and other addictive substances.

GLP-1 medication scams are rising fast. Learn how fake pharmacies, ads, and messages work — and how to spot them early.

Sally Lyons Wyatt, from Data analytics company Circana, says GLP-1 potential users are only three percent more likely to buy ...

By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.